Accuray Incorporated (ARAY) : Advisory Services Network scooped up 3,800 additional shares in Accuray Incorporated during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 7, 2016. The investment management firm now holds a total of 25,700 shares of Accuray Incorporated which is valued at $150,859.Accuray Incorporated makes up approximately 0.03% of Advisory Services Network’s portfolio.
Other Hedge Funds, Including , Simplex Trading added ARAY to its portfolio by purchasing 727 company shares during the most recent quarter which is valued at $4,267.Bnp Paribas Arbitrage Sa boosted its stake in ARAY in the latest quarter, The investment management firm added 3,428 additional shares and now holds a total of 6,535 shares of Accuray Incorporated which is valued at $38,818.
Accuray Incorporated closed down -0.03 points or -0.51% at $5.87 with 2,21,988 shares getting traded on Friday. Post opening the session at $5.89, the shares hit an intraday low of $5.82 and an intraday high of $5.97 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Accuray Incorporated reported $-0.09 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Aug 17, 2016. Analyst had a consensus of $-0.07. The company had revenue of $95.00 million for the quarter, compared to analysts expectations of $99.46 million. The company’s revenue was down -6.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.07 EPS.
Accuray Incorporated is a radiation oncology company. The Company develops manufactures sells and supports treatment solutions. Its suite of products includes the CyberKnife Systems and the TomoTherapy Systems. Its technologies the CyberKnife and TomoTherapy Systems are designed to deliver treatments including radiosurgery stereotactic body radiation therapy intensity modulated radiation therapy image guided radiation therapy and adaptive radiation therapy. Its principal radiosurgery products the CyberKnife Systems are robotic full-body radiosurgery system designed to treat tumors anywhere in the body non-invasively which include the CyberKnife M6 Series with configuration options of fixed collimators plus iris variable aperture collimator fixed collimators plus the InCise MLC and fixed collimators plus iris variable aperture collimator and the InCise MLC. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH TomoHD and TomoHDA.